Biodexa Pharmaceuticals (BDRX)

NASDAQ: BDRX · Real-Time Price · USD

1.43

0.02 (1.42%)

At close: May 02, 2025, 10:24 AM

Biodexa Pharmaceuticals Cash Flow Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-5.73M	-7.08M	-7.66M	-5.46M	-22.19M	-10.09M	-15.03M	-16.06M	-20.16M
Depreciation & Amortization	254K	283K	343K	403K	1.22M	1.28M	1.11M	1.17M	4.35M
Stock-Based Compensation	283K	28K	123K	89K	-404K	-34K	n/a	n/a	n/a
Other Working Capital	2.24M	-414K	513K	-130K	-2.05M	1.07M	165K	n/a	n/a
Other Non-Cash Items	-3.08M	397K	454K	-892K	430K	2.33M	-1.07M	3.11M	3.21M
Deferred Income Tax	-250K	-406K	-832K	469K	13.2M	-1.78M	n/a	n/a	n/a
Change in Working Capital	-3.74M	-49K	520K	-617K	-1.56M	1.8M	1.54M	-1.17M	-479K
Operating Cash Flow	-12.26M	-6.83M	-7.05M	-6.01M	-9.3M	-6.49M	-13.45M	-12.95M	-13.09M
Capital Expenditures	-774K	-263K	-62K	-320K	-209K	-319K	-244K	-707K	-1.35M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-947K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-2.55M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	2.64M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-589K	-239K	-158K	42K	144K	-939K	9.29M	-763K	145K
Investing Cash Flow	-598K	-265K	-220K	-278K	2.57M	-3.81M	9.04M	-1.47M	-1.2M
Debt Repayment	245K	-188K	-178K	-215K	-6.18M	3.86M	-5.88M	4.68M	-239K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-13K	-18K	-15K	-476K	766K	-587K	-136K	15.49M
Financial Cash Flow	8.56M	10.23M	47K	8.8M	3.08M	18.73M	-6.47M	10.28M	15.26M
Net Cash Flow	-4.3M	3.13M	-7.22M	2.51M	-3.38M	8.59M	-10.86M	-4.4M	1.43M
Free Cash Flow	-13.04M	-7.09M	-7.11M	-6.33M	-9.51M	-6.81M	-13.69M	-13.66M	-14.43M